SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor
cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or
without doxorubicin and vinblastine in treating patients with stage I or stage II Hodgkin's
disease.
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Cancer and Leukemia Group B National Cancer Institute (NCI)